ARCHIVES

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

HHS Pick For FDA May Be Food Safety Expert.

October 5, 2001

Kerrie Wilson Succeeds Alan Davis As ACS Chief Lobbyist

November 26, 1993

Univ. Of Pittsburg Vows To Make Changes To Keep NSABP

April 8, 1994

Tempero, Johnson To Lead ASCO

March 28, 2003

ASCO Guideline On Breast Cancer Risk Reduction Updated

May 29, 2009

Duke Plans To Restart Three Trials Using Tumor Microarray Analysis

January 29, 2010